A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma

被引：7

作者：

Sandach, Patrick ^{[1
,2
]}

Seifert, Robert ^{[1
,2
]}

Fendler, Wolfgang P. ^{[1
,2
]}

Hautzel, Hubertus ^{[1
,2
]}

Herrmann, Ken ^{[1
,2
]}

Maier, Sandra ^{[3
]}

Ploenes, Till ^{[4
]}

Metzenmacher, Martin ^{[5
]}

Ferdinandus, Justin ^{[1
,2
]}

机构：

[1] Univ Duisburg Essen, Dept Nucl Med, Hufelandstr 55, D-45122 Essen, Germany

[2] German Canc Consortium DKTQ Univ Hosp Essen, Dept Nucl Med, Essen, Germany

[3] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany

[4] Univ Duisburg Essen, Univ Med Essen Ruhrlandklin, West German Canc Ctr, Dept Thorac Surg, Essen, Germany

[5] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr WTZ, Dept Med Oncol, Essen, Germany

来源：

SEMINARS IN NUCLEAR MEDICINE | 2022年 / 52卷 / 06期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; SOLID TUMORS; EVALUATION CRITERIA; LUNG-CANCER; OPEN-LABEL; COMPUTED-TOMOGRAPHY; MODIFIED RECIST; MULTICENTER; THERAPY; CHEMOTHERAPY;

D O I：

10.1053/j.semnuclmed.2022.04.008

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Malignant pleural mesothelioma is a rare type of cancer, whose incidence, however, is increasing and will presumably continue to rise in the coming years. Key features of this disease comprise its mantle-shaped, pleura-associated, often multifocal growth, which cause diagnostic challenges. A growing number of mesotheliomas are being treated with novel immunotherapies for which no image derived general response criteria have been established. However, recent studies indicate that FDG-PET/CT could be superior for response assessment compared to CT-based criteria. This article aims at providing an overview of response assessment criteria dedicated to malignant pleural mesothelioma, such as mRECIST, iRECIST, and PERCIST. In addition, the potential future role of PET/CT in the management of malignant pleural mesothelioma will also be discussed. Semin Nucl Med 52:816-823 (c) 2022 Elsevier Inc. All rights reserved.

引用

页码：816 / 823

页数：8

共 50 条

[1] Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma
Badarna, Manar
Keidar, Zohar
Arnon-Sheleg, Elite
SEMINARS IN NUCLEAR MEDICINE, 2025, 55 (02) : 252 - 263
[2] Response evaluation by CT and FDG-PET/CT in malignant pleural mesothelioma
Schaefer, N. G.
Veit, P.
Steinert, H.
Stahel, R. A.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[3] PET/CT in the management of Malignant Pleural Mesothelioma
De Rimini, M. L.
Piccolo, S.
Catalano, M.
Bifulco, M.
Borrelli, G.
Magliulo, B.
Muto, P.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S139 - S139
[4] THE ROLE OF PET/CT IN STAGING AND SURGICAL APPROACH FOR MALIGNANT PLEURAL MESOTHELIOMA
Lequaglie, Cosimo
Giudice, Gabriella
Rolfo, Christian
Marasco, Daniela R.
Della Morte, Aniello
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S486 - S486
[5] A Review of the Role of FDG-PET/CT and PET/MRI in Malignant Pleural Mesothelioma
Bural, Gonca
Torigian, Drew
Alavi, Abass
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[6] Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma
Veit-Haibach, Patrick
Schaefer, Niklaus G.
Steinert, Hans C.
Soyka, Jan D.
Seifert, Burkhardt
Stahel, Rolf A.
LUNG CANCER, 2010, 67 (03) : 311 - 317
[7] Response evaluation in malignant pleural mesothelioma (MPM) with FDG-PET/CT
Dellea, MMS
Burger, C
Hany, TF
Seifert, B
Jermann, M
Kung, M
Stahel, RA
Steinert, HC
von Schulthess, GK
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S408 - S408
[8] PET/CT and Postoperative Surveillance in Malignant Pleural Mesothelioma
不详
JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 18N - 18N
[9] PET-CT evaluation of malignant pleural mesothelioma
Gad, Youhanna
Vattoth, Surjith
McNamara, Michelle
O'Malley, Janis
JOURNAL OF NUCLEAR MEDICINE, 2010, 51
[10] Role of 18F-FDG PET/CT in Malignant Pleural Mesothelioma
Cayvarli, H.
Bekis, R.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S454 - S454

← 1 2 3 4 5 →